| pubmed-article:18635596 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0003209 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C1515999 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:18635596 | lifeskim:mentions | umls-concept:C0065055 | lld:lifeskim |
| pubmed-article:18635596 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18635596 | pubmed:dateCreated | 2009-5-13 | lld:pubmed |
| pubmed-article:18635596 | pubmed:abstractText | High-density lipoprotein (HDL) antiatherogenic functions seem to be diminished during inflammatory conditions such as rheumatoid arthritis (RA). The aim of this study was to investigate the effects of tumour necrosis factor (TNF) inhibition on the antioxidative capacity of HDL in RA. | lld:pubmed |
| pubmed-article:18635596 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18635596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18635596 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18635596 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18635596 | pubmed:issn | 1468-2060 | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:PopaCC | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:BarreraPP | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:NeteaM GMG | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:RoestMM | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:van RielP L... | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:StalenhoefA... | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:van TitsL J... | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:RadstakeT R... | lld:pubmed |
| pubmed-article:18635596 | pubmed:author | pubmed-author:LemmersH L... | lld:pubmed |
| pubmed-article:18635596 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18635596 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:18635596 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18635596 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18635596 | pubmed:pagination | 868-72 | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:meshHeading | pubmed-meshheading:18635596... | lld:pubmed |
| pubmed-article:18635596 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18635596 | pubmed:articleTitle | Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. | lld:pubmed |
| pubmed-article:18635596 | pubmed:affiliation | Department of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands. c.popa@reuma.umcn.nl | lld:pubmed |
| pubmed-article:18635596 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18635596 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:18635596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635596 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635596 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635596 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18635596 | lld:pubmed |
